<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00525772</url>
  </required_header>
  <id_info>
    <org_study_id>BY/M1-121</org_study_id>
    <secondary_id>OBCIEX</secondary_id>
    <nct_id>NCT00525772</nct_id>
  </id_info>
  <brief_title>Effect of Ciclesonide on Exercise Induced Bronchoconstriction</brief_title>
  <official_title>Effect of Ciclesonide on Exercise Induced Bronchoconstriction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hamilton Health Sciences Corporation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kolding Sygehus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Takeda</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>McMaster University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to study the effects of once daily inhaled ciclesonide at
      varying doses on exercise provoked asthma symptoms, fall in lung function after exercise and
      sputum characteristics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To study the effects of 4 doses of ciclesonide on exercise-induced bronchoconstriction,
      bronchial responsiveness to mannitol, sputum parameters and other parameters of asthma
      control in asthmatic patients. The primary aim was to evaluate exercise-induced
      bronchoconstriction as a method of determining the dose and time responses of inhaled
      corticosteroid therapy. The secondary aims were to evaluate the dose and time responses of
      sputum parameters and responsiveness to mannitol to inhaled corticosteroid therapy.
      Furthermore to explore the relationship(s) between exercise induced bronchoconstriction,
      sputum parameters and mannitol responsiveness.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2001</start_date>
  <completion_date type="Actual">November 2007</completion_date>
  <primary_completion_date type="Actual">November 2007</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in maximum fall in FEV1 induced by dry air exercise challenge after treatment compared to the respective pretreatment value</measure>
    <time_frame>at 1 week of treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in sputum cell counts,bronchial responsiveness to mannitol and other clinical parameters of asthma control after treatment compared to respective pre-treatment value.</measure>
    <time_frame>after 1, 2, 3, weeks of treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ciclesonide 50 and 200ug</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ciclesonide 100ug and 400ug</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ciclesonide</intervention_name>
    <description>low dose- 50ug and 200ug</description>
    <arm_group_label>1</arm_group_label>
    <other_name>ciclesonide (Alvesco)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ciclesonide</intervention_name>
    <description>high dose- 100ug and 400ug</description>
    <arm_group_label>2</arm_group_label>
    <other_name>ciclesonide (Alvesco)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  stable asthma not on maintenance asthma medications

          -  exercise induced bronchoconstriction on dry air exercise challenge.

        Exclusion Criteria:

          -  other significant co-morbidity or treatments that might interfere with the conduct or
             results of the study

          -  fail to return to baseline after a maximum washout period of 8 weeks

          -  unable to perform the procedures of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul O'Byrne, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>McMaster University Medical Centre</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 3Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Subbarao P, Duong M, Adelroth E, Otis J, Obminski G, Inman M, Pedersen S, O'byrne PM. Effect of ciclesonide dose and duration of therapy on exercise-induced bronchoconstriction in patients with asthma. J Allergy Clin Immunol. 2006 May;117(5):1008-13.</citation>
    <PMID>16675326</PMID>
  </reference>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2007</study_first_submitted>
  <study_first_submitted_qc>September 5, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 6, 2007</study_first_posted>
  <last_update_submitted>October 20, 2009</last_update_submitted>
  <last_update_submitted_qc>October 20, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2009</last_update_posted>
  <responsible_party>
    <name_title>Paul O'Byrne</name_title>
    <organization>McMaster University</organization>
  </responsible_party>
  <keyword>asthma</keyword>
  <keyword>exercise induced bronchoconstriction</keyword>
  <keyword>sputum eosinophils</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ciclesonide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

